reglab/housing_qa huggingface dataset:
IN Code § 16-46-16.5-4 (2021)
2021 Indiana Code|Title 16. Health|Article 46. State Health Grants and Programs|Chapter 16.5. Health Issues and Challenges Grant Program|16-46-16.5-4. Establishment of Fund; Source of Funding; Administration

Sec. 4. (a) The prevention and addressing of health issues and challenges grant fund is established for the purpose of distributing money for the grant program. The fund shall be administered by the state department.(b) The fund consists of:(1) money appropriated for the program or to the fund by the general assembly;(2) money received from state or federal grants or programs; and(3) gifts, money, and donations received from any other source, including transfers from other funds or accounts.(c) The expenses of administering the fund shall be paid from money in the fund.(d) The treasurer of state shall invest the money in the fund not currently needed to meet the obligations of the fund in the same manner as other public money may be invested. Interest that accrues from the investments shall be deposited in the fund.(e) Money in the fund at the end of the state fiscal year does not revert to the state general fund or to any other fund in the case of an appropriation made to the program from a fund other than the state general fund. In addition, if there is an appropriation for the program for a state fiscal year, the money appropriated shall be transferred to the fund at the beginning of the state fiscal year for which the appropriation is made.As added by P.L.110-2021, SEC.4.
IN Code § 16-46-16.5-5 (2021)
2021 Indiana Code|Title 16. Health|Article 46. State Health Grants and Programs|Chapter 16.5. Health Issues and Challenges Grant Program|16-46-16.5-5. Application for Grant; Requirements

Sec. 5. (a) A person seeking a grant under this chapter must submit a proposal to the state department.(b) A proposal for a grant under this chapter must include the following:(1) Proposed measurable and specific improvement in one (1) or more critical health metrics within a defined cohort. The cohort may be defined by any health, demographic, or geographic criteria, or any combination of these. However, a cohort defined using demographic criteria may include criteria based on employment in a particular industry or having particular job duties.(2) The time frame in which to achieve the proposed measurable improvement or improvements described in subdivision (1). However, the time frame in which an initial proposed measurable improvement is achieved may not be more than two (2) years.As added by P.L.110-2021, SEC.4.
IN Code § 16-46-16.5-6 (2021)
2021 Indiana Code|Title 16. Health|Article 46. State Health Grants and Programs|Chapter 16.5. Health Issues and Challenges Grant Program|16-46-16.5-6. Awarding of Grants; Priority

Sec. 6. The state department shall award grants under this chapter primarily for the purpose of increasing health outcomes by, and preventing or reducing the prevalence of, the following:(1) Training concerning mental health.(2) Tobacco or nicotine use and the pulmonary and cardiac effects from the use.(3) Food insecurities.(4) Adverse behavioral and mental health outcomes.(5) Lead exposure.(6) Obesity.(7) Diabetes.(8) Cardiovascular diseases, including hypertension and hyperlipidemia.(9) Hepatitis C.(10) Cancer.(11) Other critical health issues for a specific:(A) region;(B) county;(C) sex; or(D) ethnicity;that ranks in the bottom quintile for that specific health issue metric.In awarding the grants, the state department may give priority to proposals that will address health disparities and organizations representing people of color.As added by P.L.110-2021, SEC.4.
IN Code § 16-46-16.5-7 (2021)
2021 Indiana Code|Title 16. Health|Article 46. State Health Grants and Programs|Chapter 16.5. Health Issues and Challenges Grant Program|16-46-16.5-7. Grant Amounts; Initial Awards

Sec. 7. (a) The state department shall determine whether to award a grant under this chapter.(b) Subject to subsection (c), if the state department approves a proposal:(1) the initial grant amount awarded shall not exceed eighty-five percent (85%); or(2) if the proposal approved by the state department will supplement a health initiative that currently receives partial funding from another source, including a Medicaid provider, the initial grant amount awarded shall not exceed seventy-five percent (75%);of the total grant amount approved for the proposal. The state department shall distribute the remaining amount of the approved grant to the grantee when the state department determines that the grantee has achieved the outcome or outcomes in the grant proposal.(c) The state department of health may distribute the initial award amounts described in subsection (b)(1) and (b)(2) over the course of the project that is the subject of the proposal based on achieved objectives.As added by P.L.110-2021, SEC.4.
IN Code § 16-46-16.5-8 (2021)
2021 Indiana Code|Title 16. Health|Article 46. State Health Grants and Programs|Chapter 16.5. Health Issues and Challenges Grant Program|16-46-16.5-8. Internet Posting Tracking Metrics and Progress

Sec. 8. The management performance hub established by IC 4-3-26-8 shall develop and publish on an Internet web site a web page that tracks Indiana's metrics on the most significant areas of health and behavioral health impacting Indiana residents, as identified by the state department, and demonstrate any progress made in these metrics. The web page must include specific progress reported by organizations awarded a grant under the grant program.As added by P.L.110-2021, SEC.4.
IN Code § 16-46-16.5-9 (2021)
2021 Indiana Code|Title 16. Health|Article 46. State Health Grants and Programs|Chapter 16.5. Health Issues and Challenges Grant Program|16-46-16.5-9. Rules

Sec. 9. The state department may adopt necessary rules under IC 4-22-2 to implement this chapter.As added by P.L.110-2021, SEC.4.
IN Code § 16-47-1-0.1 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 1. State Aggregate Prescription Drug Purchasing Program|16-47-1-0.1. Application of Certain Amendments to Chapter

Sec. 0.1. The following amendments to this chapter apply as follows:(1) The addition of section 5(a)(1) of this chapter by P.L.50-2004 applies to a health benefit plan described in section 2(1) and 2(2) of this chapter, as added by P.L.50-2004, established, entered into, delivered, amended, or renewed after December 31, 2004.(2) The addition of section 5(a)(2) of this chapter by P.L.50-2004 applies to a health benefit plan described in section 2(3) of this chapter, as added by P.L.50-2004, on the date that the health benefit plan is established, entered into, delivered, amended, or renewed after December 31, 2004.As added by P.L.220-2011, SEC.325. Amended by P.L.121-2016, SEC.22.
IN Code § 16-47-1-1 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 1. State Aggregate Prescription Drug Purchasing Program|16-47-1-1. "Department"

Sec. 1. As used in this chapter, "department" refers to the state personnel department.As added by P.L.50-2004, SEC.5.
IN Code § 16-47-1-2 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 1. State Aggregate Prescription Drug Purchasing Program|16-47-1-2. "Health Benefit Plan"

Sec. 2. As used in this chapter, "health benefit plan" refers to the following:(1) A self-insurance program established under IC 5-10-8-7(b) to provide group health coverage.(2) A contract with a prepaid health care delivery plan that is entered into or renewed under IC 5-10-8-7(c).(3) A plan through which a state educational institution arranges for coverage of the cost of health care services (as defined in IC 27-13-1-18) provided to employees of the state educational institution.As added by P.L.50-2004, SEC.5. Amended by P.L.2-2007, SEC.197; P.L.121-2016, SEC.23.
IN Code § 16-47-1-3 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 1. State Aggregate Prescription Drug Purchasing Program|16-47-1-3. "Program"

Sec. 3. As used in this chapter, "program" refers to the aggregate prescription drug purchasing program established under this chapter.As added by P.L.50-2004, SEC.5.
IN Code § 16-47-1-4 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 1. State Aggregate Prescription Drug Purchasing Program|16-47-1-4. Establishing, Implementing, and Maintaining Program

Sec. 4. (a) The department, with the approval of the budget agency, shall establish, implement, and maintain an aggregate prescription drug purchasing program through which terms are negotiated related to the purchase of prescription drugs by:(1) an entity described in section 5(a) or 5(b) of this chapter; or(2) an individual who is covered under a health benefit plan that includes a prescription drug benefit.(b) The budget agency may contract with a pharmacy benefit manager or other person to conduct the negotiations of the program established under subsection (a).(c) The terms and conditions of the program are subject to the approval of the budget agency.As added by P.L.50-2004, SEC.5.
IN Code § 16-47-1-5 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 1. State Aggregate Prescription Drug Purchasing Program|16-47-1-5. Application; Participation in Program

Sec. 5. (a) This subsection does not apply to prescription drugs that are dispensed through an onsite clinic. The following shall participate in the program:(1) The department, for a health benefit plan:(A) described in section 2(1) or 2(2) of this chapter; and(B) that provides coverage for prescription drugs.(2) After June 30, 2011, a state educational institution, for a health benefit plan:(A) described in section 2(3) of this chapter; and(B) that provides coverage for prescription drugs;unless the budget agency determines that the state educational institution's participation in the program would not result in an overall financial benefit to the state educational institution. The budget agency may delay compliance with this subdivision to a date after July 1, 2011, that is determined by the budget agency to allow for the orderly transition from another program.(b) The following may participate in the program:(1) A state agency other than the department that:(A) purchases prescription drugs; or(B) arranges for the payment of the cost of prescription drugs.(2) A local unit (as defined in IC 5-10-8-1).(3) A nonprofit association of cities and towns.(4) The Indiana comprehensive health insurance association established under IC 27-8-10.(c) The state Medicaid program may not participate in the program under this chapter.As added by P.L.50-2004, SEC.5. Amended by P.L.173-2007, SEC.3; P.L.229-2011, SEC.166; P.L.46-2015, SEC.1; P.L.121-2016, SEC.24; P.L.196-2021, SEC.14; P.L.207-2021, SEC.20.
IN Code § 16-47-1-6 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 1. State Aggregate Prescription Drug Purchasing Program|16-47-1-6. Approval of Request for Proposals by Budget Agency

Sec. 6. A request for proposal and the award of a contract under this chapter is subject to the approval of the budget agency.As added by P.L.50-2004, SEC.5.
IN Code § 16-47-1-7 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 1. State Aggregate Prescription Drug Purchasing Program|16-47-1-7. Prohibition on Importing Drugs in Violation of Federal Law

Sec. 7. The program may not include the purchase of prescription drugs imported into the United States in violation of federal law.As added by P.L.50-2004, SEC.5.
IN Code § 16-47-1-8 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 1. State Aggregate Prescription Drug Purchasing Program|16-47-1-8. Voluntary Participation by Pharmaceutical Manufacturers; Prohibition on Penalizing Manufacturers

Sec. 8. (a) Participation in the program by a pharmaceutical manufacturer is voluntary.(b) The state may not:(1) require prior authorization for a prescription drug in the state Medicaid program under IC 12-15; or(2) otherwise penalize a pharmaceutical manufacturer;because the pharmaceutical manufacturer is not participating in the program.As added by P.L.50-2004, SEC.5.
IN Code § 16-47-1-9 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 1. State Aggregate Prescription Drug Purchasing Program|16-47-1-9. Confidentiality of Information

Sec. 9. Any information, including prescription drug prices and discounts, provided to the state or the state's contractor under this chapter is confidential and is exempt from disclosure under IC 5-14-3.As added by P.L.50-2004, SEC.5.
IN Code § 16-47-1-10 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 1. State Aggregate Prescription Drug Purchasing Program|16-47-1-10. Negotiations by Drug Stores to Participate in Program

Sec. 10. A drug store may negotiate prescription drug prices and discounts with a pharmaceutical manufacturer to participate in the program.As added by P.L.50-2004, SEC.5.
IN Code § 16-47-2-1 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 2. Multi-State Prescription Drug Aggregate Purchasing Program|16-47-2-1. Authority to Enter Into Multi-State Agreement to Purchase or Reimburse for Prescription Drugs

Sec. 1. The state, with the approval of the governor, may enter into agreements with other states to jointly purchase prescription drugs in aggregate or provide for reimbursement of the cost of prescription drugs purchased in aggregate to reduce the prescription drug costs for the state and for Indiana residents covered under this chapter.As added by P.L.50-2004, SEC.5.
IN Code § 16-47-2-2 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 2. Multi-State Prescription Drug Aggregate Purchasing Program|16-47-2-2. Prohibition on Medicaid Program Participating in Program

Sec. 2. The state Medicaid program may not participate in a program entered into under this chapter.As added by P.L.50-2004, SEC.5.
IN Code § 16-47-2-3 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 2. Multi-State Prescription Drug Aggregate Purchasing Program|16-47-2-3. Prohibition on Purchasing Imported Prescription Drugs in Violation of Federal Law

Sec. 3. The program described in this chapter may not include the purchase of prescription drugs imported into the United States in violation of federal law.As added by P.L.50-2004, SEC.5.
IN Code § 16-47-2-4 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 2. Multi-State Prescription Drug Aggregate Purchasing Program|16-47-2-4. Voluntary Participation in Program by Pharmaceutical Manufacturers; Prohibition on Penalizing Manufacturers

Sec. 4. (a) Participation in the program described in this chapter by a pharmaceutical manufacturer is voluntary.(b) The state may not participate in a program described in this chapter that:(1) requires prior authorization of a prescription drug in the state Medicaid program under IC 12-15; or(2) otherwise penalizes a pharmaceutical manufacturer;because a pharmaceutical manufacturer does not participate in the program.As added by P.L.50-2004, SEC.5.
IN Code § 16-47-2-5 (2021)
2021 Indiana Code|Title 16. Health|Article 47. Aggregate Purchasing of Prescription Drugs|Chapter 2. Multi-State Prescription Drug Aggregate Purchasing Program|16-47-2-5. Confidentiality of Information

Sec. 5. Any information, including prescription drug prices and discounts, provided to the state or to the state's contractor under this chapter is confidential and is exempt from disclosure under IC 5-14-3.As added by P.L.50-2004, SEC.5.
IN Code § 16-48-1-0.5 (2021)
2021 Indiana Code|Title 16. Health|Article 48. Other Health Care Providers and Services|Chapter 1. Anatomic Pathology Services|16-48-1-0.5. Application and Construction of Chapter

Sec. 0.5. (a) This chapter may not be construed to apply to an anatomic pathology service that is:(1) billed to a hospital by a clinical laboratory; or(2) billed by the hospital for an inpatient or outpatient facility of the hospital.(b) This chapter may not be construed to prohibit a physician who has performed the anatomic pathology service on a patient sample from billing a patient or payer for the histological processing of the sample if the histological processing is performed by another physician or a clinical laboratory. The physician who performed the anatomic pathology service may combine the cost for the histological processing of the sample and for the anatomic pathology service for billing purposes, but may not add a fee for the histological processing of the sample.As added by P.L.3-2013, SEC.1.
IN Code § 16-48-1-1 (2021)
2021 Indiana Code|Title 16. Health|Article 48. Other Health Care Providers and Services|Chapter 1. Anatomic Pathology Services|16-48-1-1. "Anatomic Pathology Service"

Sec. 1. As used in this chapter, "anatomic pathology service" means any of the following performed by a physician or under the supervision of a physician on a sample taken from a human body:(1) Histopathology or surgical pathology, meaning the gross and microscopic examination and histologic processing of organ tissue.(2) Cytopathology, meaning the microscopic examination of cells from the following:(A) Fluids.(B) Aspirates.(C) Washings.(D) Brushings.(E) Smears.(3) Hematology, meaning the microscopic evaluation of bone marrow aspirates and biopsies, and peripheral blood smears when the attending or treating physician or technologist requests that a blood smear be reviewed by a pathologist.(4) Subcellular pathology and molecular pathology, meaning the assessment of a specimen for detection, localization, measurement, or analysis of protein or nucleic acid targets.(5) Blood banking services performed by pathologists.As added by P.L.222-2011, SEC.1.
IN Code § 16-48-1-2 (2021)
2021 Indiana Code|Title 16. Health|Article 48. Other Health Care Providers and Services|Chapter 1. Anatomic Pathology Services|16-48-1-2. "Physician"

Sec. 2. As used in this chapter, "physician" includes a physician group practice.As added by P.L.222-2011, SEC.1.
IN Code § 16-48-1-3 (2021)
2021 Indiana Code|Title 16. Health|Article 48. Other Health Care Providers and Services|Chapter 1. Anatomic Pathology Services|16-48-1-3. "Provider"

Sec. 3. As used in this chapter, "provider" means a health care provider or a clinical laboratory.As added by P.L.222-2011, SEC.1.
IN Code § 16-48-1-4 (2021)
2021 Indiana Code|Title 16. Health|Article 48. Other Health Care Providers and Services|Chapter 1. Anatomic Pathology Services|16-48-1-4. "Second Opinion"

Sec. 4. As used in this chapter, "second opinion" means consultation, histologic processing, or additional testing performed on a sample by a second provider after an anatomic pathology service is performed on the sample by a first provider.As added by P.L.222-2011, SEC.1.
IN Code § 16-48-1-5 (2021)
2021 Indiana Code|Title 16. Health|Article 48. Other Health Care Providers and Services|Chapter 1. Anatomic Pathology Services|16-48-1-5. Billing, Claims, Demand for Payment for Anatomic Pathology Service; Second Opinion

Sec. 5. (a) Except as provided in subsection (b), a provider shall not present a bill, claim, or other demand for payment for an anatomic pathology service unless the anatomic pathology service was performed:(1) within the provider's office;(2) by a physician or under the direct supervision of a physician; and(3) in accordance with Section 353 of the federal Public Health Service Act (42 U.S.C. 263a).(b) If a sample taken from a human body is sent:(1) by a provider that has performed an anatomic pathology service; and(2) to a second provider for a second opinion;the provider described in subdivision (1) may present a bill, claim, or other demand for payment for the second opinion.As added by P.L.222-2011, SEC.1.
IN Code § 16-48-1-6 (2021)
2021 Indiana Code|Title 16. Health|Article 48. Other Health Care Providers and Services|Chapter 1. Anatomic Pathology Services|16-48-1-6. Recipient of Bill, Claim, Other Demand for Payment for Anatomic Pathology Service

Sec. 6. (a) Except as provided in subsection (b), a bill, claim, or other demand for payment permitted by section 5 of this chapter may be presented only to the following:(1) The patient.(2) The patient's insurer or other third party payer.(3) A government agency, or another agency or organization, that serves as a payment source on behalf of the patient.(4) The hospital, health clinic, public health clinic, or rural health clinic.(b) If a provider described in section 5(b)(1) of this chapter presents a bill, claim, or other demand for payment for a second opinion as permitted by section 5(b) of this chapter, the second provider may bill the provider described in section 5(b)(1) for the second opinion.As added by P.L.222-2011, SEC.1.
IN Code § 16-48-1-7 (2021)
2021 Indiana Code|Title 16. Health|Article 48. Other Health Care Providers and Services|Chapter 1. Anatomic Pathology Services|16-48-1-7. Violations

Sec. 7. A person is not required to reimburse a provider for charges or claims submitted in violation of this chapter.As added by P.L.222-2011, SEC.1.
IN Code § 16-48-1-8 (2021)
2021 Indiana Code|Title 16. Health|Article 48. Other Health Care Providers and Services|Chapter 1. Anatomic Pathology Services|16-48-1-8. License or Certification; Consequences for Violation

Sec. 8. If a provider violates this chapter, the state entity that has jurisdiction over licensing or certification of the provider may revoke, suspend, or refuse to renew the license or certification of the provider.As added by P.L.222-2011, SEC.1.
IN Code § 16-48-1-9 (2021)
2021 Indiana Code|Title 16. Health|Article 48. Other Health Care Providers and Services|Chapter 1. Anatomic Pathology Services|16-48-1-9. Assignment of Benefits Not Required

Sec. 9. This chapter does not require assignment of benefits for an anatomic pathology service.As added by P.L.222-2011, SEC.1.
IN Code § 16-49-1-1 (2021)
2021 Indiana Code|Title 16. Health|Article 49. Child Fatality Reviews|Chapter 1. Definitions|16-49-1-1. Application of Definitions

Sec. 1. The definitions in this chapter apply throughout this article.As added by P.L.119-2013, SEC.3.
IN Code § 16-49-1-2 (2021)
2021 Indiana Code|Title 16. Health|Article 49. Child Fatality Reviews|Chapter 1. Definitions|16-49-1-2. "Child"

Sec. 2. "Child" means an individual less than eighteen (18) years of age.As added by P.L.119-2013, SEC.3.
IN Code § 16-49-1-3 (2021)
2021 Indiana Code|Title 16. Health|Article 49. Child Fatality Reviews|Chapter 1. Definitions|16-49-1-3. "Child Fatality Committee"

Sec. 3. "Child fatality committee" means a child fatality committee established under IC 16-49-2-1.As added by P.L.119-2013, SEC.3.
IN Code § 16-49-1-4 (2021)
2021 Indiana Code|Title 16. Health|Article 49. Child Fatality Reviews|Chapter 1. Definitions|16-49-1-4. "County Child Fatality Review Team"

Sec. 4. "County child fatality review team" means a child fatality review team established by a child fatality committee under IC 16-49-2 for a county.As added by P.L.119-2013, SEC.3.
IN Code § 16-49-1-5 (2021)
2021 Indiana Code|Title 16. Health|Article 49. Child Fatality Reviews|Chapter 1. Definitions|16-49-1-5. "Emergency Medical Services"

Sec. 5. "Emergency medical services" means the provision of emergency ambulance services or other services, including extrication and rescue services, used in serving an individual's need for immediate medical care in order to prevent loss of life or aggravation of physiological or psychological illness or injury.As added by P.L.119-2013, SEC.3.